Effect of Pesticide Exposure on HER-2/neu Overexpression Seen in Patients with Extensive Stage Small Cell Lung Carcinoma

Clinical Cancer Research

Volumn 9, Issue 13, 2003, Pages 4872-4876

  Potti, Anil ^a,d   Ganti, Apar Kishor ^a   Sholes, Kaley ^a   Langness, Eric ^a   Koka, Vijay ^a   Horvarth, Linda ^c   Koch, Michael ^b  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

^b Department of Pathology ^*  (United States)

^c Fargo VA Medical Center   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBICIDE; INSECTICIDE; ONCOPROTEIN; PESTICIDE;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; CALCULATION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; EVALUATION; FEMALE; GENE OVEREXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERVIEW; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE NEU; PARAMETER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUESTIONNAIRE; RANK SUM TEST; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SMOKING; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PESTICIDES; QUESTIONNAIRES; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0142219326     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Minna, J. D., Pass, H., Glatstein, E. Cancer of the lung. In: V. T. De Vita, S. Hellman, S. A. Rosemberg (eds.), Cancer: Principles and Practice of Oncology, Ed. 3, pp. 591-705. Philadelphia: J. B. Lippincott, 1989.
2. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1996. CA - Cancer J. Clin., 65: 5-27, 1996.
3. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer statistics, 1994. CA - Cancer J. Clin., 44: 7-26, 1994.
4. Hoffman, P. C., Mauer, A. M., and Vokes, E. E. Lung cancer. Lancet, 355: 479-475, 2000.
5. Chute, J. P., Venzon, D. J., Hankins, L., Okunieff, P., Frame, J. N., Ihde, D. C., and Johnson, B. E. Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute. Mayo Clin. Proc., 72: 901-912, 1997.
6. Potti, A., Willardson, J., Forseen, C., Ganti, A. K., Hebert, B., Levitt, R., and Mehdi, S. A. Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma. Lung Cancer, 36: 257-261, 2002.
7. Micke, P., Hengstler, J. G., Ros, R., Bittinger, F., Metz, T., Gebhard, S., Beeh, K. M., Oesch, F., and Buhl, R. c-erbB-2 expression in small cell lung cancer is associated with poor response. Int. J. Cancer, 92: 474-479, 2001.
8. Schneider, P. M., Hung, M. C., Chiocca, S. M., Manning, J., Zhao, X. Y., Fang, K., and Roth, J. A. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res., 49: 4968-4971, 1989.
9. Hirsch, F. R., Franklin, W. A., Veve, R., Varella-Garcia, M., and Bunn, P. A., Jr. HER2/neu expression in malignant lung tumors. Semin. Oncol., 29: 51-58, 2002.
10. Bunn, P. A., Jr., Helfrich, B., Soriano, A. F., Franklin, W. A., Varella-Garcia, M., Hirsch, F. R., Baron, A., Zeng, C., and Chan, D. C. Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. Clin. Cancer Res., 7: 3239-3250. 2001.
11. Farrow, A., Jacobs, A., and West, R. R. Myelodysplasia, chemical exposure, and other environmental factors. Leukemia (Baltimore), 3: 33-35, 1989.
12. Brown, L. M., Blair, A., Gibson, R., Everett, G. D., Cantor, K. P., Schuman, L. M., Burmeister, L. F., Van Lier, S. F., and Dick, F. Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res., 50: 6585-6591, 1990.
13. Zahm, S. H., and Blair, A. Pesticides and non-Hodgkin's lymphoma. Cancer Res. 52: 5485s-5488s, 1992.
14. Jimenez, R. E., Wallis, T., Tabasczka, P., and Visscher, D. W. Determination of HER-2/neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization. Mod. Pathol., 13: 37-45, 2000.
15. Buehler, H., Bangemann, N., Evers, K., Becker, C., and Schaller, G. Effective HER-2/neu diagnosis in breast cancer by a combination of immunochemistry and FISH. Proc. Am. Soc. Clin. Oncol., 19: 76a, 2000.
16. Mass, R. D., Sanders, C., Charlene, K., Johnson, L., Everett, T., and Anderson, S. The concordance between the clinical trials assay (CTA) and fluorescence in situ hybridization (FISH) in the Herceptin pivotal trials. Proc. Am. Soc. Clin. Oncol., 19: 75a, 2000.
17. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
18. McCann, A. H., Dervan, P. A., O'Regan, M., Codd, M. B., Gullick, W. J., Tobin, B. M., and Carney, D. N. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. Cancer Res., 51: 3296-3303, 1991.
19. Weiner, D. B., Nordberg, J., Robinson, R., Nowell, P. C., Gazdar, A., Greene, M. I., Williams, W. V., Cohen, J. A., and Kern, J. A. Expression of neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res., 50: 421-425, 1990.
20. Zhang, X., Silva, E., Greshenson, D., and Hung, M. C. Amplification and rearrangement of c-erbB proto-oncogenes in cancer of human female genital tract. Oncogene, 4: 985-989, 1989.
21. Yokota, J., Yamamoto, T., Miyajima, N. Toyoshima, K., Nomura, N., Sakamoto, H., Yoshida, T., Terada, M., and Sugimura, T. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene, 2: 283-287, 1988.
22. Dugan, M. C., Dergham, S. T., Kucway, R., Singh, K., Biernat, L., Du, W., Vaitkevicius, V. K., Crissman, J. D., and Sarkar, F. H. HER2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survival. Pancreas, 14: 229-236, 1997.
23. Kapitanovic, S., Radosevic, S., Kapitanovic, M., Andelinovic, S., Ferencic, Z., Tavassoli, M., Primorac, D., Sonicki, Z., Spaventi, S., Pavelic, K., and Spaventi, R. The expression of p185 (HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. Gastroenterology, 112: 1103-1113, 1997.
24. Riben, M. W., Malfetano, J. H., Nazeer, T., Muraca, P. J., Ambros, R. A., and Ross, J. S. Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma. Mod. Pathol., 10: 823-831, 1997.
25. Costa, M. J., Walls, J., and Trelford, J. D. C-erbB-2 oncoprotein over-expression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease. Am. J. Clin. Pathol., 104: 634-642, 1995.
26. Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., and Slamon, D. J. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol., 17: 2639-2648, 1999.
27. Dich, J., Zahm, S. H., Hanberg, A., and Adami, H. O. Pesticides and cancer. Cancer Causes Control, 8: 420-443, 1997.
28. Wicklund, K. G., Daling, J. R., Allard, J., and Weiss, N. S. Respiratory cancer among orchardists in Washington State, 1968 to 1980. J. Occup. Med., 30: 561-564, 1988.
29. McDuffie, H. H., Klaassen, D. J., Dosman, J. A. Is pesticide use related to the risk of primary lung cancer in Saskatchewan? J. Occup. Med., 32: 996-1002, 1990.
30. Blair, A., Grauman, D. J., Lubin, J. H., and Fraumeni, J. F., Jr. Lung cancer and other causes of death among licensed pesticide applicators. J. Natl. Cancer Inst. (Bethesda), 71: 31-37, 1983.
31. De Stefani, E., Kogevinas, M., Boffetta, P., Ronco, A., and Mendilaharsu, M. Occupation and the risk of lung cancer in Uruguay. Scand. J. Work Environ. Health, 22: 346-352, 1996.
32. Becher, H., Flesch-Janys, D., Kauppinen, T., Kogevinas, M., Steindorf, K., Manz, A., and Wahrendorf, J. Cancer mortality in German male workers exposed to phenoxy herbicides and dioxins. Cancer Causes Control, 7: 312-321, 1996.
33. Pesatori, A. C., Sontag, J. M., Lubin, J. H., Consonni, D., and Blair, A. Cohort mortality and nested case-control study of lung cancer among structural pest control workers in Florida (United States). Cancer Causes Control, 5: 310-318, 1994.
34. Tessier, D. M., and Matsumura, F. Increased ErbB-2 tyrosine kinase activity, MAPK phosphorylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides. Toxicol. Sci., 60: 38-43, 2001.
35. Enan, E., and Matsumura, F. Activation of c-Neu tyrosine kinase by o, p'-DDT and β-HCH in cell-free and intact cell preparations from MCF-7 human breast cancer cells. J. Biochem. Mol. Toxicol., 12: 83-92, 1998.
36. Gazdar, A. F. The molecular and cellular basis of human lung cancer. Anticancer Res., 14: 261-267, 1994.
37. Coughlin, S. S. Recall bias in epidemiologic studies. J. Clin. Epidemiol., 43: 87-91, 1990.
38. Teschke, K., Smith, J. C., and Olshan, A. F. Evidence of recall bias in volunteered versus prompted responses about occupational exposures. Am. J. Ind. Med., 38: 385-388, 2000.